









Markets
/
Stocks
/
nasdaq-veev
/

Veeva Systems Inc

VEEV

291.200USD

+6.170+2.16%

Close 10/31, 16:00（ET）Quotes delayed by 15 min

47.72BMarket Cap

58.92P/E TTM



Veeva Systems Inc

291.200

+6.170+2.16%

Overview Company Financials Analysis

TradingKey Stock Score

Overall Financial Health

Valuation Dimensions

Earnings Forecast

Price Momentum

Institutional Confidence

Risk Assessment

Peer Comparison

Overview

Company

Financials

Analysis

TradingKey Stock Score

Overall Financial Health

Valuation Dimensions

Earnings Forecast

Price Momentum

Institutional Confidence

Risk Assessment

Peer Comparison

TradingKey Stock Score of Veeva Systems Inc

Currency: USD Updated: 2025-10-31

Key Insights

The company's fundamentals are relatively very healthy. Its valuation is considered fairly valued,and institutional recognition is very high. Over the past 30 days, multiple analysts have rated the company as a Buy. Despite an average stock market performance, the company shows strong fundamentals and technicals. The stock price is trading sideways between the support and resistance levels, making it suitable for range-bound swing trading.

Veeva Systems Inc's Score

Industry at a Glance

Industry Ranking

50 / 210

Overall Ranking

143 / 4618

Industry

Healthcare Equipment & Supplies

Support & Resistance

No Data

Score Analysis

Current score

Previous score

Analyst Rating

Based on 34 analysts

Buy

Current Rating

317.201

Target Price

+11.29%

Upside Space

Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.

Veeva Systems Inc Highlights

StrengthsRisks

Veeva Systems Inc. is a provider of cloud solutions for the global life sciences industry. The Company offers span cloud software, data, and business consulting and is designed to meet the needs of its customers and their strategic business functions from research and development (R&D) through commercialization. The Company’s three product categories: Veeva Development Cloud, Veeva Commercial Cloud, and Veeva Data Cloud. Veeva Development Cloud includes application suites for the clinical, regulatory, and safety functions of life sciences companies, all built on its Veeva Vault platform. Veeva Vault Clinical advances clinical trial execution by providing a complete and connected technology ecosystem. Veeva Commercial Cloud is a product category comprised of software and analytics solutions. Its software offerings include Veeva CRM, Veeva Vault PromoMats, Veeva Vault Medical, and Veeva Crossix. Its data offerings include Veeva OpenData, Veeva Link, and Veeva Compass.

High Growth

The company's revenue has grown steadily over the past 3 years, averaging 27.45% year-on-year.

High Profit Growth

The company's net income leads the industry, with the latest annual income totaling USD 2.75B.

Fairly Valued

The company’s latest PE is 58.49, at a medium 3-year percentile range.

Institutional Selling

The latest institutional holdings are 145.31M shares, decreasing 0.42% quarter-over-quarter.

Held by Chase Coleman

Star Investor Chase Coleman holds 2.42M shares of this stock.

Financial Health

Currency: USD Updated: 2025-10-31

The company's current financial score is 7.44, which is lower than the Healthcare Equipment & Supplies industry's average of 7.46. Its financial status is robust, and its operating efficiency is high. Its latest quarterly revenue reached 789.08M, representing a year-over-year increase of 16.70%, while its net profit experienced a year-over-year increase of 17.11%.

Score

Industry at a Glance

Previous score

7.44

Change



Financials

10.00

Key Metrics

Cash and cash equivalents

Total assets

Total liabilities

Free cash flow

No Data



Quality of Earnings

2.59

Key Metrics

Total revenue

Operating profit

Total assets

SG&A

No Data



Operational Efficiency

8.33

Key Metrics

Cash flow from operating activities

Income after tax

No Data



Growth Potential

8.79

Key Metrics

Cash flow from operating activities

Total revenue

No Data



Shareholder Returns

7.46

Key Metrics

Free cash flow

No Data

Veeva Systems Inc's Company Valuation

Currency: USD Updated: 2025-10-31

The company’s current valuation score is 6.40, which is lower than the Healthcare Equipment & Supplies industry's average of 7.19. Its current P/E ratio is 58.49, which is 27.96% below the recent high of 74.84 and 20.94% above the recent low of 46.24.

Score

Industry at a Glance

Previous score

6.40

Change

Valuation Dimensions

P/E

P/B

P/S

P/CF

Industry Ranking 50/210

No Data

Earnings Forecast

Currency: USD Updated: 2025-10-31

The company’s current earnings forecast score is 7.70, which is lower than the Healthcare Equipment & Supplies industry's average of 7.74. The average price target for Veeva Systems Inc is 325.00, with a high of 380.00 and a low of 222.00.

Score

Industry at a Glance

Previous score

7.70

Change

Support & Resistance

No Data

Analyst Rating

Based on 34 analysts

Buy

Current Rating

317.201

Target Price

+11.29%

Upside Space

Strong Buy

Buy

Hold

Sell

Strong Sell

Peer Comparison

Total

Median

Average

Company name

Ratings

Analysts

Veeva Systems Inc

VEEV

Boston Scientific Corp

BSX

Edwards Lifesciences Corp

Intuitive Surgical Inc

ISRG

Thermo Fisher Scientific Inc

TMO

Danaher Corp

DHR

...

Financial Forecasting

EPS

Revenue

Net Profit

EBIT

No Data

Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.

Price Momentum

Currency: USD Updated: 2025-10-31

The company’s current price momentum score is 7.13, which is higher than the Healthcare Equipment & Supplies industry's average of 6.65. Sideways: Currently, the stock price is trading between the resistance level at 308.24 and the support level at 276.42, making it suitable for range-bound swing trading.

Score

Industry at a Glance

Previous score

6.79

Change

0.34

Support & Resistance

No Data

Indicators



The Indicators feature provides value and direction analysis for various instruments under a selection of technical indicators, together with a technical summary.

This feature includes nine of the commonly used technical indicators: MACD, RSI, KDJ, StochRSI, ATR, CCI, WR, TRIX and MA. You may also adjust the timeframe depending on your needs.

Please note that technical analysis is only part of investment reference, and there is no absolute standard for using numerical values to assess direction. The results are for reference only, and we are not responsible for the accuracy of the indicator calculations and summaries.

Indicators

Sell(1)

Neutral(4)

Buy(2)

Indicators

Value

Direction

MACD(12,26,9)

-1.264

Neutral

RSI(14)

52.061

Neutral

STOCH(KDJ)(9,3,3)

46.320

Neutral

ATR(14)

6.930

Low Volatility

CCI(14)

3.222

Neutral

Williams %R

34.540

Buy

TRIX(12,20)

0.032

Sell

StochRSI(14)

57.613

Buy

Moving Average

Sell(1)

Neutral(0)

Buy(5)

Indicators

Value

Direction

MA5

289.988

Buy

MA10

290.015

Buy

MA20

291.528

Sell

MA50

285.582

Buy

MA100

284.078

Buy

MA200

259.501

Buy

Institutional Confidence

Currency: USD Updated: 2025-10-31

The company’s current institutional recognition score is 7.00, which is higher than the Healthcare Equipment & Supplies industry's average of 6.43. The latest institutional shareholding proportion is 88.65%, representing a quarter-over-quarter decrease of 7.21%. The largest institutional shareholder is The Vanguard, holding a total of 14.90M shares, representing 9.09% of shares outstanding, with 2.65% increase in holdings.

Score

Industry at a Glance

Previous score

7.00

Change

Institutional Shareholding

No Data

Shareholder Activity

Name

Shares Held

Chg %

The Vanguard Group, Inc.

Star Investors

14.90M

+1.42%

Gassner (Peter P)

12.27M

BlackRock Institutional Trust Company, N.A.

6.81M

-1.94%

AllianceBernstein L.P.

5.71M

+3.75%

Fidelity Management & Research Company LLC

5.15M

-3.00%

T. Rowe Price Investment Management, Inc.

4.43M

-14.83%

Principal Global Investors (Equity)

3.46M

+9.70%

State Street Investment Management (US)

3.43M

-0.98%

Geode Capital Management, L.L.C.

3.09M

+3.83%

Tiger Global Management, L.L.C.

Star Investors

2.42M

Risk Assessment

Currency: USD Updated: 2025-10-31

The company’s current risk assessment score is 8.91, which is higher than the Healthcare Equipment & Supplies industry's average of 4.56. The company's beta value is 0.97. This indicates that the stock tends to underperform the index during upward trending markets but experiences smaller declines during downward trending markets.